The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; MSD; Novartis; Pfizer; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; MSD; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche
Olaparib in German routine clinical practice: Updated interim results of the non-interventional study C-PATROL.
 
Frederik Marme
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Genomic Health; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; Eisai; Novartis; Pfizer; PharmaMar; Roche
 
Felix Hilpert
No Relationships to Disclose
 
Manfred Welslau
Honoraria - Bristol-Myers Squibb; Janssen; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Janssen; Novartis (I); Roche
 
Ahmed El-Balat
Honoraria - AstraZeneca; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche
Travel, Accommodations, Expenses - Clovis Oncology; PharmaMar; Tesaro
 
Eva-Maria Grischke
No Relationships to Disclose
 
Timo Schinkothe
Consulting or Advisory Role - AstraZeneca
 
Regina Glowik
Employment - AstraZeneca
Honoraria - AstraZeneca
 
Jalid Sehouli
Honoraria - AstraZeneca; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Novocure; Roche; Tesaro
Research Funding - Amgen; Bayer; Lilly; Novartis